Chemopreventive effects of Khaya senegalensis bark extract on human colorectal cancer

ISSN: 02507005
32Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

An extract of the bark of Khaya senegalensis is commonly used in African traditional medicine for pain and inflammation. Khaya senegalensis bark extract (KSBE) was hypothesized to contain inhibitors of the cyclooxygenase-2 (COX-2) gene and to be useful in the prevention and treatment of colorectal cancer. The diphenyl-2-picrylhydrazyl (DPPH)-free radical activity and the total phenolic content of KSBE were measured, followed by an investigation of cell growth inhibition, COX and prostaglandin E 2 (PGE2) suppression, as well as apoptosis by Western blot analysis and ELISA. Our data clearly showed that KSBE displays anti-proliferative, antiinflammatory and pro-apoptotic effects on HT-29, HCT-15 and HCA-7 cells. Since all three cell lines, irrespective of COX-2 status (HCT-15 is COX-2-deficient), were affected by the treatment, it can be concluded that both COX-dependent and COX-independent pathways are activated by KSBE.

Cite

CITATION STYLE

APA

Androulakis, X. M., Muga, S. J., Chen, F., Koita, Y., Toure, B., & Wargovich, M. J. (2006). Chemopreventive effects of Khaya senegalensis bark extract on human colorectal cancer. Anticancer Research, 26(3 B), 2397–2405.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free